Elevated serum levels of soluble CD14 in HBeAg-positive chronic HBV patients upon Peginterferon treatment are associated with treatment response

Author(s):: Dou, Y.Y.; Montfoort, N. van; Bosch, A. van den; Janssen, H.L.A.; Man, R.A. de; Buschow, S.I.; Woltman, A.M.

Published: 2019
Publication type: Article / Letter to editor

clinical outcomeHBeAgHBVPEG-IFNsCD14

Date issued: 2019-09-30
Language: English
Is part of: Journal of Viral Hepatitis (2019), Vol. 26, no. 9, p. 1076-1085
hdl: 1887/121319
doi: 10.1111/jvh.13127